Search Results - "Boivin, Isabel"
-
1
Mubritinib Targets the Electron Transport Chain Complex I and Reveals the Landscape of OXPHOS Dependency in Acute Myeloid Leukemia
Published in Cancer cell (08-07-2019)“…To identify therapeutic targets in acute myeloid leukemia (AML), we chemically interrogated 200 sequenced primary specimens. Mubritinib, a known ERBB2…”
Get full text
Journal Article -
2
Genetic characterization of ABT-199 sensitivity in human AML
Published in Leukemia (01-01-2020)“…Acute myeloid leukemias (AML) with mutations in the NPM1 gene (NPM1c+) represent a large AML subgroup with varying response to conventional treatment,…”
Get full text
Journal Article -
3
Chemo-genomic interrogation of CEBPA mutated AML reveals recurrent CSF3R mutations and subgroup sensitivity to JAK inhibitors
Published in Blood (16-06-2016)“…In this study, we analyzed RNA-sequencing data of 14 samples characterized by biallelic CEBPA (CEBPAbi) mutations included in the Leucegene collection of 415…”
Get full text
Journal Article -
4
RNA-sequencing analysis of core binding factor AML identifies recurrent ZBTB7A mutations and defines RUNX1-CBFA2T3 fusion signature
Published in Blood (19-05-2016)Get full text
Journal Article -
5
Immunotherapeutic targeting of surfaceome heterogeneity in AML
Published in Cell reports (Cambridge) (25-06-2024)“…Immunotherapy remains underexploited in acute myeloid leukemia (AML) compared to other hematological malignancies. Currently, gemtuzumab ozogamicin is the only…”
Get full text
Journal Article -
6
HLF expression defines the human hematopoietic stem cell state
Published in Blood (23-12-2021)“…Hematopoietic stem cells (HSCs) sustain blood cell homeostasis throughout life and can regenerate all blood lineages after transplantation. Despite this clear…”
Get full text
Journal Article -
7
H3K27M/I mutations promote context-dependent transformation in acute myeloid leukemia with RUNX1 alterations
Published in Blood (16-11-2017)“…Neomorphic missense mutations affecting crucial lysine residues in histone H3 genes significantly contribute to a variety of solid cancers. Despite the high…”
Get full text
Journal Article -
8
GPR56 identifies primary human acute myeloid leukemia cells with high repopulating potential in vivo
Published in Blood (21-04-2016)“…Acute myeloid leukemia (AML) is a genetically heterogeneous hematologic malignancy, which is initiated and driven by a rare fraction of leukemia stem cells…”
Get full text
Journal Article -
9
High frequency of germline RUNX1 mutations in patients with RUNX1-mutated AML
Published in Blood (21-05-2020)“…RUNX1 is mutated in ∼10% of adult acute myeloid leukemia (AML). Although most RUNX1 mutations in this disease are believed to be acquired, they can also be…”
Get full text
Journal Article -
10
Disruption of Intracellular Metal Homeostasis As a Vulnerability in SF3B1 Mutated AML
Published in Blood (15-11-2022)Get full text
Journal Article -
11
3019 – CRISPR-BASED ENGINEERING OF A REPORTER ALLELE DEMONSTRATES THAT HLF EXPRESSION DEFINES THE HUMAN HAEMATOPOIETIC STEM CELL STATE
Published in Experimental hematology (01-08-2020)“…Haematopoietic stem cells (HSCs) sustain blood cell homeostasis throughout life and are able to regenerate all blood lineages following transplantation…”
Get full text
Journal Article -
12
DELE1 haploinsufficiency causes resistance to mitochondrial stress-induced apoptosis in monosomy 5/del(5q) AML
Published in Leukemia (01-03-2024)“…Monosomy 5 and deletions of the chromosome 5q (−5/del(5q)) are recurrent events in de novo adult acute myeloid leukemia (AML), reaching up to 40% of cases in…”
Get full text
Journal Article -
13
Identification of Acute Myeloid Leukemia Cell Surface Therapeutic Targets Using Single Cell RNA Sequencing Supported By Surface Proteomics
Published in Blood (02-11-2023)“…Background: Acute myeloid leukemia (AML) comprises diverse genomic subgroups and remains hard to treat in most patients. Despite breakthroughs in the…”
Get full text
Journal Article -
14
Chemogenomic Profiling of Complex Karyotype AML Reveals a Novel Susceptibility to G2/M Checkpoint Inhibition Mediated By HMGA2 Overexpression
Published in Blood (29-11-2018)“…Background: Acute myeloid leukemia (AML) with complex karyotype (CK) is associated with adverse prognosis with current therapies, in particular in the presence…”
Get full text
Journal Article -
15
Identification of Novel Antigens for Normal Karyotype Triple Mutated Acute Myeloid Leukemia
Published in Blood (15-11-2022)Get full text
Journal Article -
16
Identification of Novel Cell Surface Therapeutic Targets for KMT2A-Rearranged Acute Myeloid Leukemia
Published in Blood (15-11-2022)Get full text
Journal Article -
17
Comparative small molecule screening of primary human acute leukemias, engineered human leukemia and leukemia cell lines
Published in Leukemia (29-10-2024)“…Targeted therapeutics for high-risk cancers remain an unmet medical need. Here we report the results of a large-scale screen of over 11,000 molecules for their…”
Get full text
Journal Article -
18
3114 – HMGA2 OVEREXPRESSION CONFERS SENSITIVITY TO G2/M INHIBITORS IN ACUTE MYELOID LEUKEMIA
Published in Experimental hematology (01-08-2020)“…Complex karyotype (CK) acute myeloid leukemia (AML), especially those with TP53 anomalies, are particularly resistant to current therapies and remain one of…”
Get full text
Journal Article -
19
H3K27M/I Mutations Promote Context-Dependent Transformation in Acute Myeloid Leukemia with RUNX1 Alterations
Published in Blood (08-12-2017)“…Neomorphic missense mutations in histone H3 genes (most notably K27M and K36M) are frequent in solid cancers such as diffuse intrinsic pontine gliomas (DIPG),…”
Get full text
Journal Article -
20
H3 K27M/I mutations promote context-dependent transformation in acute myeloid leukemia with RUNX1 alterations
Published in Blood (16-11-2017)“…Neomorphic missense mutations affecting crucial lysine residues in histone H3 genes significantly contribute to a variety of solid cancers. Despite the high…”
Get full text
Journal Article